MoneyWorks4Me

Hester Biosciences informs about board meeting

24 Jan 2024 Evaluate
Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months period ended 31 December 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.75
Dr. Reddys Labs. 1213.80
Cipla 1375.10
Lupin 2097.70
Zydus Lifesciences 1157.60
View more..